Patrice Matchaba
Directeur Général chez Bill & Melinda Gates Medical Research Institute
Profil
Patrice Matchaba is currently the Chief Executive Officer at the Bill & Melinda Gates Medical Research Institute.
Previously, he held the position of Medical Director-Country Pharma Organization at Novartis South Africa (Pty) Ltd.
and Head-United States Global Development at Novartis Pharmaceuticals Corp.
Dr. Matchaba completed his undergraduate degree at Harvard University.
Postes actifs de Patrice Matchaba
| Sociétés | Poste | Début |
|---|---|---|
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Directeur Général | 10/06/2024 |
Anciens postes connus de Patrice Matchaba
| Sociétés | Poste | Fin |
|---|---|---|
Novartis South Africa (Pty) Ltd.
 Novartis South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis South Africa (Pty) Ltd. is a South African company that manufactures, fabricates, and processes drugs in pharmaceutical preparations. The company is based in Gauteng, South Africa. The CEO of the company is Wolfgang Storf. | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Formation de Patrice Matchaba
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Novartis South Africa (Pty) Ltd.
Novartis South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis South Africa (Pty) Ltd. is a South African company that manufactures, fabricates, and processes drugs in pharmaceutical preparations. The company is based in Gauteng, South Africa. The CEO of the company is Wolfgang Storf. | Health Technology |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization based in Cambridge, MA. The institute focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). Bill & Melinda Gates Medical Research Institute works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. Patrice Matchaba has been the CEO of the company since 2024. | Commercial Services |
